We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+14.61%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$51.6B
AUM Growth
+$5.68B
Cap. Flow
-$429M
Cap. Flow %
-0.83%
Top 10 Hldgs %
17.19%
Holding
3,020
New
40
Increased
1,307
Reduced
1,586
Closed
73

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$73.8M
2
AMZN icon
Amazon
AMZN
+$68.6M
3
AAPL icon
Apple
AAPL
+$64.9M
4
MSFT icon
Microsoft
MSFT
+$61.4M
5
META icon
Meta Platforms (Facebook)
META
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 15.13%
3 Healthcare 13.65%
4 Consumer Discretionary 10.39%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPBK icon
2801
OP Bancorp
OPBK
$234M
$150K ﹤0.01%
17,156
-90
-0.5% -$818
SMFG icon
2802
Sumitomo Mitsui Financial
SMFG
$161B
$150K ﹤0.01%
21,345
-5,780
-21% -$41.3K
GDP
2803
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$150K ﹤0.01%
11,066
-160
-1% -$2.15K
INAP
2804
DELISTED
Internap Corporation
INAP
$150K ﹤0.01%
30,245
+3,190
+12% +$17.2K
AM icon
2805
Antero Midstream
AM
$10B
$147K ﹤0.01%
+10,698
New +$140K
NGVC icon
2806
Vitamin Cottage Natural Grocers
NGVC
$736M
$147K ﹤0.01%
12,288
-170
-1% -$2.4K
AGFS
2807
DELISTED
AgroFresh Solutions Inc
AGFS
$147K ﹤0.01%
43,995
-240
-0.5% -$950
GENC icon
2808
Gencor Industries
GENC
$213M
$145K ﹤0.01%
11,694
-60
-0.5% -$784
FNM
2809
DELISTED
FANNIE MAE
FNM
$144K ﹤0.01%
51,556
-16,519
-24% -$46.1K
FSK icon
2810
FS KKR Capital
FSK
$3.09B
$143K ﹤0.01%
5,916
UPL
2811
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$143K ﹤0.01%
233,685
-1,180
-0.5% -$860
SLDB icon
2812
Solid Biosciences
SLDB
$860M
$140K ﹤0.01%
1,013
-30
-3% -$7.52K
SPRO icon
2813
Spero Therapeutics
SPRO
$73M
$140K ﹤0.01%
10,893
+883
+9% +$9.37K
NEOS
2814
DELISTED
Neos Therapeutics, Inc
NEOS
$140K ﹤0.01%
53,730
+16,288
+44% +$38.2K
MNTX
2815
DELISTED
Manitex International, Inc.
MNTX
$140K ﹤0.01%
18,356
-310
-2% -$2.26K
VIVS
2816
VivoSim Labs
VIVS
$1.25M
$139K ﹤0.01%
585
-11
-2% -$2.77K
HSDT icon
2817
Solana Company
HSDT
$100M
0
SAN icon
2818
Banco Santander
SAN
$209B
$137K ﹤0.01%
30,845
-2,674
-8% -$12.2K
SCTL
2819
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$137K ﹤0.01%
26,087
-398
-2% -$2.95K
CURO
2820
DELISTED
CURO Group Holdings Corp.
CURO
$137K ﹤0.01%
13,647
-473
-3% -$5.16K
GYRE icon
2821
Gyre Therapeutics
GYRE
$697M
$136K ﹤0.01%
2,243
-24
-1% -$1.54K
CMRX
2822
DELISTED
Chimerix, Inc.
CMRX
$135K ﹤0.01%
64,430
-1,415
-2% -$3.22K
DOVA
2823
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$135K ﹤0.01%
15,154
-189
-1% -$1.53K
SNDA icon
2824
Sonida Senior Living
SNDA
$1.89B
$134K ﹤0.01%
2,246
-41
-2% -$3.71K
TRAK icon
2825
ReposiTrak
TRAK
$157M
$134K ﹤0.01%
16,798
-300
-2% -$2.34K

Similar funds

RhumbLine Advisers's Q1 2019 Portfolio in Review

As of Q1 2019, RhumbLine Advisers held 3,020 positions worth $51.6B, up 12% from $46B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 3.7%. RhumbLine Advisers opened 40 new positions and exited 73, leaving the 3,020-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2019 buy was Fox Class A: 602,636 shares worth $22.1M.
  • RhumbLine Advisers added most to Walt Disney in Q1 2019, an estimated $73.8M increase.
  • RhumbLine Advisers's biggest Q1 2019 reduction was Wells Fargo, cutting an estimated $16.4M.
  • RhumbLine Advisers fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $89.7M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $51.6B portfolio in Q1 2019.
  • RhumbLine Advisers opened 40 new positions and closed 73 in Q1 2019.
  • RhumbLine Advisers's portfolio value rose 12% quarter-over-quarter to $51.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.